Reduced efficacy of sumatriptan in migraine with aura vs without aura.
نویسندگان
چکیده
OBJECTIVE To determine whether acute migraine treatment outcome is different in migraine with aura compared with migraine without aura. METHODS We examined pooled outcome data for sumatriptan treatment of migraine with and without aura from the sumatriptan/naratriptan aggregate patient database. We also examined similar outcome data for inhaled dihydroergotamine (DHE) from a single, large randomized controlled study. RESULTS The pooled pain-free rates 2 hours postdose for sumatriptan 100 mg were significantly higher in patients treating attacks without aura (32%) compared with the group who treated attacks with aura (24%) (p < 0.001). The relative risk for pain freedom 2 hours postdose for attacks without aura was 1.33 (95% confidence interval: 1.16-1.54). The number needed to treat for 2 hours of pain freedom was 4.4 for attacks without aura and 6.2 for attacks with aura. For the clinical trial of DHE, the 2-hour pain-free rates did not differ between patients treating attacks without aura (29.4%) compared with those who treated attacks with aura (27.2%; p = 0.65). The relative risk for pain freedom 2 hours postdose for attacks without aura vs with aura was 1.08 (95% confidence interval: 0.77-1.53). The number needed to treat for 2 hours pain free was 5.8 for attacks without aura and 5.0 for attacks with aura. CONCLUSION This post hoc analysis of pooled data from multiple randomized trials indicates that sumatriptan is less effective as acute therapy for migraine attacks with aura compared with attacks without aura. In the single study of inhaled DHE, the treatment had similar efficacy for migraine attacks with and without aura. Different responses of migraine with vs without aura to acute therapies may provide insight into underlying migraine mechanisms and influence the choice of acute therapies for different types of migraine attacks.
منابع مشابه
Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
OBJECTIVE To study the efficacy and practicality of treating headache in professional footballers with intranasal sumatriptan. METHODS An open label drug trial was performed in elite Australian footballers using intranasal sumatriptan (20 mg) treatment for acute headache. The main outcome measures were treatment response at 30 minutes, two hours, and 24 hours using two criteria: (a) initial s...
متن کاملInterictal and postictal contingent negative variation in migraine without aura.
Cortical hyperexcitability is thought to explain the more enhanced contingent negative variation (CNV) amplitudes and impaired CNV habituation that have been found during the interictal period in migraine without aura. These CNV characteristics have been shown to normalize to the level of healthy controls during an attack. This study aimed to replicate the interictal findings, and additionally ...
متن کاملDoes the presence of aura inform us regarding migraine severity and response to treatment?
In 1944, Leão described cortical spreading depression, the phenomenon now widely believed to underlie what some persons with headache perceive as “aura.” Aura is a somewhat misleading term because it can occur before a migraine, during or after a migraine, or occur without any associated headache. It can also occur with many other types of headache, but in clinical practice it is usually in ass...
متن کاملAre triptans effective and safe when taken during the aura phase of migraine?
CLINICAL HISTORY A 28-year-old woman has migraine with visual aura about two times per month. The visual aura lasts about 30 minutes and is followed by a hemicranial throbbing headache, which becomes severe associated with nausea, light, and noise sensitivity with a duration of up to 24 hours. Questions.—Would an oral triptan or sumatriptan administered subcutaneously be more effective if given...
متن کاملCerebral hypercapnia-induced vasomotor reactivity in migraine with and without aura: a case-control study
Abstract Background: Dysfunction of the autonomic nervous system has long been a subject of considerable debate and a large number of studies have disclosed contradictory results. The aim of this study was to compare cerebral vasomotor reactivity in migraine with aura (MWA) patients with migraine without aura (MWO) ones. Methods: Ten MWA patients (7 females and 3 males mean age: 39.70 years, S...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Neurology
دوره 84 18 شماره
صفحات -
تاریخ انتشار 2015